Search research articles
Contact Us
Filters
Showing results (501-510 of 578) with videos related to
Page
of 58
Sort By:
European Journal of Haematology
|
July 5, 2017
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, et al.
Hematological Oncology
|
August 22, 2018
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group
Sotirios G Papageorgiou, Christos K Kontos, Ioannis Kotsianidis, et al.
Leukemia & Lymphoma
|
November 15, 2018
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system
Panagiotis T Diamantopoulos, Ioannis Kotsianidis, Argiris Symeonidis, et al.
Haematologica
|
April 10, 2025
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry
Bente Houtman, Adele Taylor, Corine Van Marrewijk, et al.
British Journal of Haematology
|
February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies
Aleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
The Lancet. Haematology
|
October 4, 2023
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
Frontiers in Surgery
|
June 3, 2026
Advancing abdominal surgery recovery implementation: a unified framework for intensified recovery protocols by the EUropean PErioperative MEdical Networking collaborative
Orestis Ioannidis, Aikaterini Antonia Bourtzinakou, Jose M Ramirez, et al.
Medicina (Kaunas, Lithuania)
|
May 25, 2024
A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and <i>CTLA4</i>-Mediated Immune Dysregulation Syndrome in Greece
Androniki Kapousouzi, Fani Kalala, Styliani Sarrou, et al.
Leukemia
|
May 24, 2019
A revised international prognostic score system for Waldenström's macroglobulinemia
Efstathios Kastritis, Pierre Morel, Alain Duhamel, et al.
European Journal of Haematology
|
January 13, 2026
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis
Noemi Puig, Xavier Leleu, Hans C Lee, et al.
Page
of 58
Search research articles
Search
Showing results (501-510 of 578) with videos related to
Sort By:
Page
of 58
European Journal of Haematology
|
July 5, 2017
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, et al.
Hematological Oncology
|
August 22, 2018
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group
Sotirios G Papageorgiou, Christos K Kontos, Ioannis Kotsianidis, et al.
Leukemia & Lymphoma
|
November 15, 2018
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system
Panagiotis T Diamantopoulos, Ioannis Kotsianidis, Argiris Symeonidis, et al.
Haematologica
|
April 10, 2025
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry
Bente Houtman, Adele Taylor, Corine Van Marrewijk, et al.
British Journal of Haematology
|
February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies
Aleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
The Lancet. Haematology
|
October 4, 2023
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
Frontiers in Surgery
|
June 3, 2026
Advancing abdominal surgery recovery implementation: a unified framework for intensified recovery protocols by the EUropean PErioperative MEdical Networking collaborative
Orestis Ioannidis, Aikaterini Antonia Bourtzinakou, Jose M Ramirez, et al.
Medicina (Kaunas, Lithuania)
|
May 25, 2024
A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and <i>CTLA4</i>-Mediated Immune Dysregulation Syndrome in Greece
Androniki Kapousouzi, Fani Kalala, Styliani Sarrou, et al.
Leukemia
|
May 24, 2019
A revised international prognostic score system for Waldenström's macroglobulinemia
Efstathios Kastritis, Pierre Morel, Alain Duhamel, et al.
European Journal of Haematology
|
January 13, 2026
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis
Noemi Puig, Xavier Leleu, Hans C Lee, et al.
Page
of 58